Sea Run has shown that salmon blood products can successfully compete against mammalian blood products. Companies in the bovine/human blood field have an interest in not changing from a mammalian product to a fish product, yet a fish blood source can have as many applications and be much safer than either bovine or human blood sources. In fact, some of Sea Run's products offer distinct advantages

Scientists at Sea Run Holdings believe that a transmissible spongiform encephalopathy (TSE), like mad-cow disease, may occur in humans in the U.S. It is, in their opinion, a serious danger, since a TSE, chronic wasting disease, has already been documented in deer and elk in the U.S. and Canada. At this juncture, a gradual change to salmon, rather than bovine blood products could be prudent, if not necessary in the near future.

Sea Run Holdings is offering a large supply of an alternative blood source that can continue to provide the same benefits as bovine or human blood for countless applications.